Arvinas, Inc. (ARVN)
USD 6.48
(-6.09%)
USD 6.48
(-6.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 644.6 Million USD | -8.42% |
| 2022 | 703.9 Million USD | -12.0% |
| 2021 | 799.9 Million USD | 964.96% |
| 2020 | 75.11 Million USD | 0.21% |
| 2019 | 74.95 Million USD | 19.71% |
| 2018 | 62.61 Million USD | -5.99% |
| 2017 | 66.6 Million USD | 378.96% |
| 2016 | 13.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 581.1 Million USD | -14.47% |
| 2024 Q1 | 602.9 Million USD | -6.47% |
| 2024 Q2 | 679.4 Million USD | 12.69% |
| 2023 Q3 | 601.1 Million USD | -3.03% |
| 2023 FY | 644.6 Million USD | -8.42% |
| 2023 Q2 | 619.9 Million USD | -6.75% |
| 2023 Q4 | 644.6 Million USD | 7.24% |
| 2023 Q1 | 664.8 Million USD | -5.55% |
| 2022 Q1 | 765 Million USD | -4.36% |
| 2022 Q4 | 703.9 Million USD | -1.32% |
| 2022 Q3 | 713.3 Million USD | -3.14% |
| 2022 Q2 | 736.4 Million USD | -3.74% |
| 2022 FY | 703.9 Million USD | -12.0% |
| 2021 FY | 799.9 Million USD | 964.96% |
| 2021 Q3 | 787.12 Million USD | 1188.69% |
| 2021 Q2 | 61.07 Million USD | -8.12% |
| 2021 Q4 | 799.9 Million USD | 1.62% |
| 2021 Q1 | 66.47 Million USD | -11.5% |
| 2020 Q3 | 66.82 Million USD | 3.13% |
| 2020 Q1 | 70.74 Million USD | -5.62% |
| 2020 FY | 75.11 Million USD | 0.21% |
| 2020 Q4 | 75.11 Million USD | 12.4% |
| 2020 Q2 | 64.8 Million USD | -8.4% |
| 2019 Q4 | 74.95 Million USD | 0.03% |
| 2019 Q3 | 74.93 Million USD | 34.92% |
| 2019 Q1 | 58.83 Million USD | -6.04% |
| 2019 FY | 74.95 Million USD | 19.71% |
| 2019 Q2 | 55.54 Million USD | -5.59% |
| 2018 Q1 | 64.84 Million USD | -2.64% |
| 2018 FY | 62.61 Million USD | -5.99% |
| 2018 Q4 | 62.61 Million USD | 0.08% |
| 2018 Q3 | 62.56 Million USD | 1.38% |
| 2018 Q2 | 61.71 Million USD | -4.84% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 66.6 Million USD | 0.0% |
| 2017 FY | 66.6 Million USD | 378.96% |
| 2016 FY | 13.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -91.973% |
| Alkermes plc | 933.53 Million USD | 30.951% |
| Agenus Inc. | 462.29 Million USD | -39.435% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 84.086% |
| Aptorum Group Limited | 5.25 Million USD | -12162.357% |
| Ardelyx, Inc. | 130.76 Million USD | -392.953% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -34.744% |
| Bicycle Therapeutics plc | 224.41 Million USD | -187.24% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -395.046% |
| ChromaDex Corporation | 26.5 Million USD | -2331.719% |
| Chimerix, Inc. | 19.74 Million USD | -3164.624% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1732.441% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -788.283% |
| CRISPR Therapeutics AG | 346.76 Million USD | -85.888% |
| Precision BioSciences, Inc. | 140.92 Million USD | -357.423% |
| Dyadic International, Inc. | 2.34 Million USD | -27439.347% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -3863.598% |
| Fortress Biotech, Inc. | 165.93 Million USD | -288.456% |
| Lantern Pharma Inc. | 2.73 Million USD | -23428.278% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -801.791% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -18167.221% |
| Incyte Corporation | 1.59 Billion USD | 59.517% |
| IO Biotech, Inc. | 17.55 Million USD | -3571.679% |
| Jaguar Health, Inc. | 45.86 Million USD | -1305.398% |
| Novavax, Inc. | 2.57 Billion USD | 74.94% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1687.675% |
| Opthea Limited | 264.6 Million USD | -143.612% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -393.164% |
| ContextLogic Inc. | 206 Million USD | -212.913% |
| MiMedx Group, Inc. | 96.33 Million USD | -569.158% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1242.301% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -18166.383% |
| NextCure, Inc. | 14.99 Million USD | -4198.193% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -15847.551% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -9554.036% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1279.148% |
| Vaxcyte, Inc. | 167.44 Million USD | -284.953% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1838.114% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -174.048% |
| Pharming Group N.V. | 244.07 Million USD | -164.101% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -5306.811% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -404.417% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9655.907% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -9655.907% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -681.968% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -9603.447% |
| Acelyrin, Inc. | 86.35 Million USD | -646.471% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -49513.582% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -4382.926% |
| Summit Therapeutics Inc. | 125.25 Million USD | -414.622% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -6700.295% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1126.151% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -837.232% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -325.445% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -32855.01% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -48164.254% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -184.175% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -6781.606% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -183.409% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -30.352% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -5806.176% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2243.063% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -5225.205% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -32.47% |
| Immix Biopharma, Inc. | 3.72 Million USD | -17219.656% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1604.75% |
| MEI Pharma, Inc. | 8.35 Million USD | -7615.141% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2121.61% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -85.454% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -341.903% |
| Fortress Biotech, Inc. | 165.93 Million USD | -288.456% |
| Precigen, Inc. | 41.64 Million USD | -1447.882% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1191.007% |
| AlloVir, Inc. | 45.01 Million USD | -1331.967% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -394.564% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -367.779% |
| ImmuCell Corporation | 18.81 Million USD | -3325.985% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2183.71% |
| Onconetix, Inc. | 23.18 Million USD | -2680.739% |
| PureTech Health plc | 125.58 Million USD | -413.286% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -7102.235% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1780.287% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -26264.008% |
| Seer, Inc. | 39.36 Million USD | -1537.495% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -942.469% |
| Innoviva, Inc. | 568.55 Million USD | -13.376% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2267.416% |
| ESSA Pharma Inc. | 3.49 Million USD | -18343.116% |
| GlycoMimetics, Inc. | 6.9 Million USD | -9239.222% |
| GT Biopharma, Inc. | 6.63 Million USD | -9618.076% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -143.806% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -136.736% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -667.144% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -6495.048% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2272.557% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -19882.807% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -773.832% |
| Aptose Biosciences Inc. | 15.8 Million USD | -3977.501% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -5738.934% |
| Soligenix, Inc. | 7.27 Million USD | -8760.598% |
| Century Therapeutics, Inc. | 175.94 Million USD | -266.373% |
| Kura Oncology, Inc. | 51.66 Million USD | -1147.726% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -431.489% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -15496.419% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -9646.207% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -155.188% |
| Autolus Therapeutics plc | 263.9 Million USD | -144.253% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -6049.59% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -625.403% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1274.443% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -82.681% |
| GRI Bio, Inc. | 2.69 Million USD | -23800.63% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -79521.04% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1973.269% |
| IGM Biosciences, Inc. | 220.17 Million USD | -192.764% |
| INmune Bio, Inc. | 18.86 Million USD | -3317.453% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -151.327% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2319.505% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -23612.426% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -19550.845% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1002.729% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -570.348% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -143.489% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 21.68% |
| Verastem, Inc. | 71.18 Million USD | -805.528% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1210.802% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1570.901% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1217.338% |
| Histogen Inc. | 5.69 Million USD | -11214.727% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -14598.086% |
| Surrozen, Inc. | 8.14 Million USD | -7814.058% |
| Organovo Holdings, Inc. | 2.74 Million USD | -23357.06% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -205279.503% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1046.365% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -3803.828% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1161.374% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -77856.16% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -408.66% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -5861.018% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -327.201% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -24622.467% |
| Apollomics, Inc. | 14.15 Million USD | -4454.511% |
| Amarin Corporation plc | 279.58 Million USD | -130.554% |
| Mesoblast Limited | 188.79 Million USD | -241.423% |
| Turnstone Biologics Corp. | 14.14 Million USD | -4456.121% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -256.55% |
| Synaptogenix, Inc. | 5.52 Million USD | -11557.539% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -9596.149% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -278.936% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7432.844% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -36579.331% |
| Exelixis, Inc. | 678.44 Million USD | 4.989% |
| Better Therapeutics, Inc. | 23.84 Million USD | -2603.632% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -292.939% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -8.48% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5935.465% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -39601.506% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1555.92% |
| Gritstone bio, Inc. | 125.91 Million USD | -411.916% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4292.205% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -12567.464% |
| Avid Bioservices, Inc. | 275.66 Million USD | -133.832% |
| Insmed Incorporated | 1.66 Billion USD | 61.21% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -8277.931% |
| MediWound Ltd. | 27.18 Million USD | -2270.986% |
| OmniAb, Inc. | 87.4 Million USD | -637.529% |
| Alector, Inc. | 487.66 Million USD | -32.18% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -59.77% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -3398.507% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1579.827% |
| Zai Lab Limited | 240.17 Million USD | -168.385% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -2.308% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2105.495% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -577.977% |
| Immunic, Inc. | 25.36 Million USD | -2440.997% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -831.019% |
| Veracyte, Inc. | 93.71 Million USD | -587.801% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -24534.335% |
| FibroGen, Inc. | 585.72 Million USD | -10.051% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3608.221% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -98602.142% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -11297.839% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 91.581% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -7762.893% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -667.18% |
| TG Therapeutics, Inc. | 169.08 Million USD | -281.228% |
| Galecto, Inc. | 5.89 Million USD | -10832.836% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -7681.265% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 75.382% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2136.486% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -5007.361% |
| XBiotech Inc. | 8.39 Million USD | -7576.551% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -4292.205% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1112.11% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -77.524% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2297.709% |
| Theravance Biopharma, Inc. | 169 Million USD | -281.411% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 46.973% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -28.81% |
| Vaxxinity, Inc. | 30.94 Million USD | -1983.118% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 33.716% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -10587.922% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 13.504% |
| NexImmune, Inc. | 5.08 Million USD | -12578.414% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -173462.308% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -20863.638% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 90.93% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -12406.718% |
| Scopus BioPharma Inc. | 7.45 Million USD | -8547.202% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2351.51% |
| Ainos, Inc. | 7.39 Million USD | -8617.616% |
| Pluri Inc. | 34.11 Million USD | -1789.658% |
| Prothena Corporation plc | 135.01 Million USD | -377.421% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -165.155% |
| Celularity Inc. | 102.92 Million USD | -526.257% |
| Rallybio Corporation | 9.43 Million USD | -6731.284% |
| Cue Biopharma, Inc. | 24.44 Million USD | -2536.94% |
| MeiraGTx Holdings plc | 319.99 Million USD | -101.443% |
| Omeros Corporation | 403.25 Million USD | -59.85% |
| Humacyte, Inc. | 114.67 Million USD | -462.101% |
| Immunocore Holdings plc | 228.15 Million USD | -182.524% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -13122.564% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -739.979% |
| Blueprint Medicines Corporation | 918.64 Million USD | 29.831% |
| CalciMedica, Inc. | 4.02 Million USD | -15902.979% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -3593.559% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -318.183% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -651.133% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -132.043% |
| Pulmatrix, Inc. | 15.96 Million USD | -3938.088% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -3986.73% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -2519.686% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -157.009% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1169.247% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 46.755% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1928.128% |
| Nutriband Inc. | 1.07 Million USD | -59644.985% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -5962.259% |
| Vor Biopharma Inc. | 59.1 Million USD | -990.62% |
| Roivant Sciences Ltd. | 773.95 Million USD | 16.713% |
| Evogene Ltd. | 17.99 Million USD | -3483.102% |
| ProKidney Corp. | 29.21 Million USD | -2106.325% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -795.539% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -91334.829% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 65.875% |
| CorMedix Inc. | 11.91 Million USD | -5308.84% |
| BioLineRx Ltd. | 50.7 Million USD | -1171.35% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -331.289% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -628.847% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1211.175% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1969.189% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -3488.687% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -417.186% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -11300.778% |
| MediciNova, Inc. | 3.89 Million USD | -16464.081% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -3426.451% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -42752.176% |
| GeoVax Labs, Inc. | 3.51 Million USD | -18213.119% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -62.262% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2000.358% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 76.317% |
| Mereo BioPharma Group plc | 15.96 Million USD | -3938.341% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1965.959% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -998.425% |
| Absci Corporation | 58.3 Million USD | -1005.585% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3284.082% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1910.48% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -773.56% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -636.829% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1808.795% |
| Allakos Inc. | 74.79 Million USD | -761.845% |
| Imunon, Inc. | 8.53 Million USD | -7456.48% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -2764.762% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -461.44% |
| BioAtla, Inc. | 48.98 Million USD | -1215.886% |
| NLS Pharmaceutics AG | 10.68 Million USD | -5935.465% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -23095.394% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -393.553% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -4434.647% |
| XOMA Corporation | 145.58 Million USD | -342.781% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1814.748% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -837.477% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1940.067% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -942.654% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1333.559% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1231.763% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -22359.93% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -7801.429% |
| Akari Therapeutics, Plc | 4.58 Million USD | -13961.955% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3535.004% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 60.921% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -159490.798% |
| UroGen Pharma Ltd. | 243.52 Million USD | -164.698% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -100.756% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -23241.896% |
| Orgenesis Inc. | 35.53 Million USD | -1713.986% |
| Entera Bio Ltd. | 1.37 Million USD | -46644.017% |
| GH Research PLC | 6.7 Million USD | -9519.46% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -9379.412% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -3323.988% |
| Xencor, Inc. | 283.55 Million USD | -127.325% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -21489.758% |
| Replimune Group, Inc. | 113.21 Million USD | -469.364% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -17056.736% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -522.621% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -159490.798% |
| Portage Biotech Inc. | 4.45 Million USD | -14385.393% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -42752.176% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -2696.529% |
| OncoCyte Corporation | 49.29 Million USD | -1207.558% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -15482.074% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -80729.208% |
| Purple Biotech Ltd. | 10 Million USD | -6342.779% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -11040.684% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1025.723% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -5103.414% |
| HilleVax, Inc. | 78.9 Million USD | -716.89% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -12664.356% |
| Tharimmune, Inc. | 1.81 Million USD | -35414.251% |
| Genprex, Inc. | 3.25 Million USD | -19708.199% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2276.931% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -12210.924% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -312812.621% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -179680.671% |
| OKYO Pharma Limited | 7.42 Million USD | -8586.341% |
| Savara Inc. | 37.19 Million USD | -1633.168% |
| Curis, Inc. | 57.61 Million USD | -1018.864% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2348.171% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1544.396% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -44539.889% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2996.21% |
| BeiGene, Ltd. | 2.23 Billion USD | 71.143% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2927.741% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -145.658% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2929.99% |
| Erasca, Inc. | 78.61 Million USD | -719.987% |
| bluebird bio, Inc. | 424.62 Million USD | -51.805% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -98274.366% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 65.895% |
| DBV Technologies S.A. | 42.8 Million USD | -1406.075% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -98274.366% |
| Moderna, Inc. | 4.57 Billion USD | 85.901% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -9115.154% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -38825.121% |
| Molecular Templates, Inc. | 31.17 Million USD | -1967.948% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -3676.216% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -9.607% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -417.73% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2249.382% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1668.159% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1058.623% |
| MacroGenics, Inc. | 154.2 Million USD | -318.01% |
| RenovoRx, Inc. | 4.46 Million USD | -14333.498% |
| Adicet Bio, Inc. | 37.12 Million USD | -1636.53% |
| Prime Medicine, Inc. | 60.78 Million USD | -960.546% |
| Aditxt, Inc. | 28.53 Million USD | -2159.253% |
| Adagene Inc. | 45.16 Million USD | -1327.074% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -356621.878% |
| Quantum-Si incorporated | 26.63 Million USD | -2320.487% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 7.593% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -21086.956% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -460.712% |
| SciSparc Ltd. | 1.59 Million USD | -40313.793% |
| Vericel Corporation | 127.7 Million USD | -404.757% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11483.329% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -655.171% |
| Generation Bio Co. | 171.63 Million USD | -275.575% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -5480.952% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1440.962% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -155.087% |
| Invivyd, Inc. | 51.71 Million USD | -1146.495% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -600.827% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -9808.918% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -753.82% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -63034.182% |
| 2seventy bio, Inc. | 310.12 Million USD | -107.851% |
| ADMA Biologics, Inc. | 193.97 Million USD | -232.309% |
| Clene Inc. | 38.95 Million USD | -1554.9% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1683.972% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -150.841% |
| GeoVax Labs, Inc. | 3.51 Million USD | -18213.119% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -238.794% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -5192.429% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -225.027% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -5185.86% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1239.818% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1119.886% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -74.285% |
| Evaxion Biotech A/S | 17.61 Million USD | -3558.866% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -300.549% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -320.796% |
| Trevena, Inc. | 48.26 Million USD | -1235.626% |
| Surrozen, Inc. | 8.14 Million USD | -7814.058% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2884.95% |
| Cingulate Inc. | 10.36 Million USD | -6121.488% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -23340.0% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1628.521% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -17872.854% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -4801.901% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -103.215% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -2494.068% |
| Clearmind Medicine Inc. | 3.61 Million USD | -17755.916% |
| Kronos Bio, Inc. | 54.2 Million USD | -1089.277% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1270.236% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2732.195% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3111.599% |
| Statera Biopharma, Inc. | 22.67 Million USD | -2742.596% |
| ImmunityBio, Inc. | 1.09 Billion USD | 40.883% |
| Korro Bio, Inc. | 51.75 Million USD | -1145.556% |
| Kineta, Inc. | 7.22 Million USD | -8825.505% |
| BioVie Inc. | 9.7 Million USD | -6543.902% |
| Codexis, Inc. | 49.94 Million USD | -1190.594% |
| Celularity Inc. | 102.92 Million USD | -526.257% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -569.735% |
| Celcuity Inc. | 51.45 Million USD | -1152.865% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -186635.575% |
| Cibus, Inc. | 206.11 Million USD | -212.735% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1417.599% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -2347.321% |
| IN8bio, Inc. | 8.77 Million USD | -7248.381% |
| Kodiak Sciences Inc. | 213.59 Million USD | -201.792% |
| Annexon, Inc. | 47.11 Million USD | -1268.055% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -619.894% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -568.866% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -4608.89% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 75.24% |
| Eyenovia, Inc. | 19.78 Million USD | -3158.801% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -264.004% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8292.136% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -2574.8% |
| Arcellx, Inc. | 339.75 Million USD | -89.727% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -5317.717% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -162.523% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -6640.563% |
| Moolec Science SA | 13.94 Million USD | -4522.327% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1393.789% |
| Geron Corporation | 146.12 Million USD | -341.123% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1175.627% |
| Royalty Pharma plc | 6.29 Billion USD | 89.764% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1520.575% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -218849.342% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -26100.249% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -240.777% |
| Humacyte, Inc. | 114.67 Million USD | -462.101% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2118.856% |
| 89bio, Inc. | 59.96 Million USD | -974.996% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2335.854% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -53796.321% |
| Genelux Corporation | 8.42 Million USD | -7555.582% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -9301.984% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -372.861% |
| Notable Labs, Ltd. | 4.42 Million USD | -14460.651% |
| Liquidia Corporation | 73.13 Million USD | -781.348% |
| Mustang Bio, Inc. | 17.61 Million USD | -3558.55% |
| Immunovant, Inc. | 48.95 Million USD | -1216.719% |
| Quantum-Si incorporated | 26.63 Million USD | -2320.487% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1579.389% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -20673.445% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -772.72% |
| Acasti Pharma Inc. | 11.55 Million USD | -5477.572% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -2751.237% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -23612.426% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1647.973% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -47198.219% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -10474.147% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -2495.531% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -2680.366% |
| PepGen Inc. | 34.63 Million USD | -1761.338% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -5207.971% |
| United Therapeutics Corporation | 1.18 Billion USD | 45.475% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -9129.668% |
| Solid Biosciences Inc. | 38.45 Million USD | -1576.114% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -7432.844% |
| Immuneering Corporation | 12 Million USD | -5267.929% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -205279.503% |
| Silo Pharma, Inc. | 1.56 Million USD | -40976.424% |
| Belite Bio, Inc | 4.21 Million USD | -15207.528% |
| XOMA Corporation | 145.58 Million USD | -342.781% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -26448.6% |
| Bionomics Limited | 10.15 Million USD | -6245.287% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2899.395% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2713.25% |
| uniQure N.V. | 624.01 Million USD | -3.298% |
| Cassava Sciences, Inc. | 14.19 Million USD | -4441.036% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -356621.878% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -278.767% |
| Forte Biosciences, Inc. | 3.66 Million USD | -17483.197% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -247268.401% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -9453.876% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -8292.136% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -3608.221% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -5999.546% |
| Altimmune, Inc. | 16.54 Million USD | -3796.983% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -4.354% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -2713.25% |
| Compugen Ltd. | 55.77 Million USD | -1055.715% |
| Peak Bio, Inc. | 20.75 Million USD | -3006.002% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -483.544% |
| Benitec Biopharma Inc. | 4.96 Million USD | -12890.73% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -308.38% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -757.477% |
| Zura Bio Limited | 21.29 Million USD | -2927.428% |
| PolyPid Ltd. | 17.46 Million USD | -3590.176% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -473.493% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -757.477% |
| Instil Bio, Inc. | 99.8 Million USD | -545.885% |
| argenx SE | 444.95 Million USD | -44.87% |
| Immunome, Inc. | 28.65 Million USD | -2149.285% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -7631.798% |
| Verona Pharma plc | 58.84 Million USD | -995.495% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -4353.811% |
| Shattuck Labs, Inc. | 14.85 Million USD | -4238.112% |
| CervoMed Inc. | 2.59 Million USD | -24732.929% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -13125.277% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -4961.244% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -6018.652% |
| Moolec Science SA | 13.94 Million USD | -4522.327% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -27405.82% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1059.451% |
| AnaptysBio, Inc. | 364.28 Million USD | -76.949% |
| Design Therapeutics, Inc. | 11.95 Million USD | -5291.435% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -4981.993% |
| NeurAxis, Inc. | 1.91 Million USD | -33600.364% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1555.878% |
| Lumos Pharma, Inc. | 13.33 Million USD | -4734.621% |
| Achilles Therapeutics plc | 19.08 Million USD | -3277.168% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -4353.811% |
| 180 Life Sciences Corp. | 5.38 Million USD | -11865.379% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -2632.747% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -2732.195% |
| Nutriband Inc. | 1.07 Million USD | -59644.985% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2006.674% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -4342.147% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -60.638% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1885.034% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -4839.806% |
| Palisade Bio, Inc. | 2.73 Million USD | -23434.137% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -12171.083% |
| Beam Therapeutics Inc. | 478.38 Million USD | -34.745% |
| Neurogene Inc. | 36.54 Million USD | -1663.66% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -61.98% |
| AEON Biopharma, Inc. | 159.88 Million USD | -303.155% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1252.781% |
| Sesen Bio, Inc. | 30.98 Million USD | -1980.429% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2382.955% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -8379.107% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -229.318% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -235.63% |
| Athira Pharma, Inc. | 30.05 Million USD | -2044.592% |
| Vaccinex, Inc. | 5.94 Million USD | -10748.199% |
| HCW Biologics Inc. | 15.05 Million USD | -4182.504% |
| XOMA Corporation | 145.58 Million USD | -342.781% |
| Nektar Therapeutics | 267.04 Million USD | -141.382% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -3535.004% |
| Merus N.V. | 102.15 Million USD | -531.027% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -340.451% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -577.67% |
| Rezolute, Inc. | 11.73 Million USD | -5393.438% |
| Clene Inc. | 38.95 Million USD | -1554.9% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -22538.355% |
| BeyondSpring Inc. | 48.26 Million USD | -1235.433% |
| Synlogic, Inc. | 32.89 Million USD | -1859.568% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -4311.141% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -39349.204% |
| Peak Bio, Inc. | 20.75 Million USD | -3006.002% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -915.774% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1523.105% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -71.143% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -547.39% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -148862.623% |
| MannKind Corporation | 721.36 Million USD | 10.642% |
| Ikena Oncology, Inc. | 22.33 Million USD | -2786.053% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -30801.246% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -528.326% |
| Gossamer Bio, Inc. | 249.14 Million USD | -158.723% |
| CohBar, Inc. | 1.03 Million USD | -62262.258% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -5930.499% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3284.082% |
| Legend Biotech Corporation | 589.93 Million USD | -9.267% |
| Mural Oncology plc | 37.92 Million USD | -1599.536% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -385.992% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -27983.083% |
| Disc Medicine, Inc. | 22.87 Million USD | -2717.923% |
| Champions Oncology, Inc. | 28.03 Million USD | -2199.269% |
| REGENXBIO Inc. | 262.22 Million USD | -145.817% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -19088.224% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -5042.812% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -4699.121% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2939.849% |
| Vaxart, Inc. | 34.02 Million USD | -1794.489% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3061.468% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2159.227% |
| Cellectis S.A. | 249.57 Million USD | -158.279% |
| Longeveron Inc. | 5.33 Million USD | -11977.946% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1441.405% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 73.2% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -967.784% |
| Revolution Medicines, Inc. | 262.39 Million USD | -145.658% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -30493.261% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -7372.757% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -5362.249% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -4490.187% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -29867.457% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 87.483% |
| Denali Therapeutics Inc. | 122.96 Million USD | -424.223% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -11483.329% |
| Veru Inc. | 32.81 Million USD | -1864.483% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -9284.19% |
| Cingulate Inc. | 10.36 Million USD | -6121.488% |
| Passage Bio, Inc. | 39.26 Million USD | -1541.791% |
| Context Therapeutics Inc. | 4.19 Million USD | -15277.954% |
| Exicure, Inc. | 8.54 Million USD | -7440.063% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2084.492% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -6047.244% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -2824.55% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -295.494% |
| Nuvalent, Inc. | 31.82 Million USD | -1925.579% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -10032.628% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -922.817% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -3481.111% |
| OmniAb, Inc. | 87.4 Million USD | -637.529% |
| Anew Medical, Inc. | 8.24 Million USD | -7721.108% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1583.508% |
| Lipocine Inc. | 2.63 Million USD | -24394.334% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2353.563% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1503.004% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2319.505% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -648.195% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -11834.827% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -679.001% |
| Ocugen, Inc. | 23.98 Million USD | -2587.737% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1289.015% |
| Q32 Bio Inc. | 233.12 Million USD | -176.5% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -7010.082% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1104.815% |
| Equillium, Inc. | 27.95 Million USD | -2205.684% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -212.016% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -11356.165% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -10410.409% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -309.722% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -828.377% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -6362.673% |
| Dominari Holdings Inc. | 4.63 Million USD | -13807.228% |
| Edesa Biotech, Inc. | 1.84 Million USD | -34901.469% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2080.133% |
| Bio-Techne Corporation | 744.34 Million USD | 13.4% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -411.186% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -87.136% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1488.663% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2126.059% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -597.921% |
| Nkarta, Inc. | 105.6 Million USD | -510.417% |
| BioCardia, Inc. | 4.59 Million USD | -13943.573% |
| Iterum Therapeutics plc | 32.66 Million USD | -1873.547% |